GAM Holding’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

GAM Holding’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-64,400	Closed	-$2.78M	–	1181
2015 Q3	$2.78M	Sell	64,400 -12,400	-16%	-$523K	0.05%	389
2015 Q2	$3.25M	Buy	+76,800	New	+$3.24M	0.05%	389
2015 Q1	–	Sell	-4,230	Closed	-$142K	–	1153
2014 Q4	$142K	Buy	+4,230	New	+$149K	﹤0.01%	979
2013 Q4	–	Sell	-53,500	Closed	-$1.47M	–	1104
2013 Q3	$1.47M	Hold	53,500	–	–	0.03%	555
2013 Q2	$1.12M	Buy	+53,500	New	+$1.04M	0.02%	507

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

GAM Holding's WX Position: Q4 2015 in Review

GAM Holding sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 64,400 shares — an estimated $2.78M sold.

GAM Holding first reported a position in WX in Q2 2013 and held it in 5 quarters. The position peaked at $3.25M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

GAM Holding reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
GAM Holding sold 64,400 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.78M.
GAM Holding first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 5 quarters.
GAM Holding's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $3.25M in Q2 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on GAM Holding's 13F filing for Q4 2015, filed 8 Feb 2016.